Intelligent Bio Solutions Inc. (INBS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.48M | -1.57M | -2.85M | -2.21M | -2.76M | -2.32M | -2.39M | -2.94M | -2.45M | -2.87M | -1.31M | -584.34K |
| Operating CF Margin % | -422.33% | -174.79% | -256.06% | -261.88% | -378.04% | -382.68% | -273.67% | -404.5% | -296.99% | -375.51% | -164.78% | -131.86% |
| Operating CF Growth % | -62.59% | 32.57% | -19.25% | 24.93% | -12.62% | 18.97% | -81.98% | -403.82% | 2.85% | -20.51% | 30.73% | 66.09% |
| Net Income | -2.86M | -2.7M | -2.98M | -3.1M | -2.55M | -2.25M | -2.69M | -2.8M | -2.99M | -1.97M | -2.43M | -2.67M |
| Depreciation & Amortization | 290.39K | 281.9K | 303.38K | 306.17K | 296.83K | 307.63K | 303.11K | 287.69K | 327.53K | 290.31K | 307.56K | 170.07K |
| Stock-Based Compensation | 0 | 73.58K | 0 | 12K | 12K | 12K | 202.04K | 12.19K | 218.31K | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -169.73K | 38.66K | 409.71K | 270.28K | -5.79K | -969.44K | -119.21K | 81.65K | -35.02K | -2.03M | 343 | -122.73K |
| Working Capital Changes | -1.74M | 736.95K | -576.91K | 304.21K | -507.75K | 574.52K | -78.37K | -530.18K | 29.39K | 839.93K | 805.47K | 2.04M |
| Change in Receivables | -489.17K | 680.06K | -312.86K | -2.78M | -389.51K | 312.5K | -271.88K | -114.05K | -140.37K | 304.68K | -431.61K | 1.11M |
| Change in Inventory | -6.7K | 37.93K | 7.04K | 48.27K | 17.79K | 37.51K | 38.75K | 100.37K | 133.16K | 21.88K | -53.03K | -270.52K |
| Change in Payables | -744.17K | 0 | -567.11K | 0 | 0 | 0 | 221.34K | -151.67K | 149.29K | 0 | 1.22M | 1.02M |
| Cash from Investing | 11.7K | -28.07K | -70.4K | -208.52K | -14.38K | -8.94K | 0 | -167.31K | 2.55K | -56.67K | 0 | -181.75K |
| Capital Expenditures | 11.11K | -68.23K | -70.4K | -208.52K | -14.38K | -8.94K | 0 | -167.31K | 2.55K | -56.67K | 0 | 0 |
| CapEx % of Revenue | 1.05% | 7.61% | 6.33% | 24.71% | 1.97% | 1.47% | - | 22.99% | 0.31% | 7.42% | 0% | - |
| Acquisitions | 592 | 40.35K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -181.75K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -191 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 10.7M | 674.65K | 3.56M | 602K | 3.32M | 631.74K | 42.45K | 5.31K | 10.77M | 3.79M | 0 | 46.11K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 10.7M | 694.79K | 3.56M | 602K | 3.3M | 0 | 34.51K | 0 | 8.53M | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -20.14K | 0 | 0 | 20.63K | 631.74K | 7.94K | 5.31K | 2.24M | 3.79M | 0 | 46.11K |
| Net Change in Cash | 6.12M | -919.73K | 640.2K | -1.79M | 564.9K | -1.75M | -2.31M | -3.09M | 8.28M | 932.6K | -1.35M | -743.3K |
| Free Cash Flow | -4.47M | -1.64M | -2.92M | -2.42M | -2.77M | -2.33M | -2.39M | -3.11M | -2.44M | -2.93M | -1.31M | -584.34K |
| FCF Margin % | -421.28% | -182.4% | -262.39% | -286.59% | -380.01% | -384.15% | -273.67% | -427.48% | -296.68% | -382.93% | -164.78% | -131.86% |
| FCF Growth % | -61.35% | 29.91% | -22.2% | 22.27% | -13.33% | 20.24% | -81.98% | -432.45% | 2.98% | -21.38% | 44.62% | 69.66% |
| FCF per Share | -2.80 | -1.72 | -3.41 | -4.59 | -4.80 | -5.14 | -6.26 | -10.23 | -11.75 | -30.81 | -6.71 | -5.81 |
| FCF Conversion (FCF/Net Income) | 1.56x | 0.59x | 0.95x | 0.72x | 1.08x | 1.03x | 0.89x | 1.06x | 0.82x | 1.46x | 0.54x | 0.22x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |